Streetbeat News

ATCH

AtlasClear Holdings, Inc.

https://www.atlasclear.com

Industry

Software - Infrastructure

AtlasClear Holdings, Inc. focuses on operating as a technology enabled financial services firm. It creates a platform for trading, clearing, settlement, and banking of financial products with a focus on the small and middle market financial services firms. The company is based in Tampa, Florida.

Open

7.00

Mkt cap

2.5M

Volume

87K

High

7.08

P/E Ratio

-0.02

52-wk high

615.60

Low

6.15

Div yield

N/A

52-wk low

6.15

AtlasClear Holdings, Inc. (NYSEAMEX: ATCH) plans to develop a technology-enabled financial services firm aimed at improving trading, clearing, settlement, and banking for small and middle market financial services firms.

Portfolio Pulse from

January 10, 2025 | 12:15 pm

AtlasClear Holdings, Inc. (NYSE: ATCH) has secured an investment agreement with Hanire LLC for up to $45 million, involving equity and convertible debt. The first $5 million tranche is expected in January 2025, pending closing conditions.

Portfolio Pulse from

December 31, 2024 | 10:00 pm

AtlasClear Holdings, Inc. (NYSE American: ATCH) plans a 1-for-60 reverse stock split effective December 31, 2024, to consolidate its shares.

Portfolio Pulse from

December 20, 2024 | 9:45 pm

AtlasClear Holdings, Inc. has appointed Jeff Sime as the new CEO of its subsidiary, Wilson-Davis & Co., Inc., effective December 16, 2024. This move underscores AtlasClear's focus on strengthening leadership to innovate in the financial sector for small institutions.

Portfolio Pulse from

December 16, 2024 | 10:30 pm

AtlasClear has filed a notification with the SEC indicating a delay in filing its transition report. This could signal potential issues with financial reporting or internal processes.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 9:30 pm

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares surged 28.3% in pre-market trading after receiving FDA approval for Motiva Implants. Other notable pre-market movers include Fangdd Network Group Ltd. (NASDAQ:DUO), Onconetix, Inc. (NASDAQ:ONCO), and Bristol-Myers Squibb Company (NYSE:BMY), which saw significant gains due to various positive developments.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 10:46 am

Telesis Bio shares surged 109.9% in pre-market trading after announcing a partnership with Beckman Coulter Life Sciences to enhance DNA and mRNA synthesis. Other notable pre-market movers include Micron Technology, which rose 15.5% following strong Q4 results, and Kintara Therapeutics, up 41.8% after adjourning a stockholder meeting.

Portfolio Pulse from Avi Kapoor

September 26, 2024 | 10:31 am

U.S. stocks mostly declined with the Dow Jones falling over 50 points. Cintas Corporation reported strong earnings, beating expectations and raising guidance. Several stocks experienced significant price movements, including AtlasClear Holdings, Eightco Holdings, and Vertex Energy, which filed for bankruptcy.

Portfolio Pulse from Avi Kapoor

September 25, 2024 | 1:53 pm

Shares of companies within the broader financial sector are trading lower amid overall weakness following concerns about recently issued US economic data.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 2:52 pm

General Dynamics Corporation (NYSE:GD) shares fell 5.2% after reporting worse-than-expected Q2 EPS results despite revenue growth. Other notable stock movements include significant gains for NuZee, Inc. (NASDAQ:NUZE) and Dermata Therapeutics, Inc. (NASDAQ:DRMA), and declines for Azitra, Inc. (NYSE:AZTR) and Tesla, Inc. (NASDAQ:TSLA).

Portfolio Pulse from Avi Kapoor

July 24, 2024 | 5:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.